Analysts' mean price target for Biodesix (BDSX) implies 104.3% upside, and the article notes broad agreement in raising earnings estimates. While the price-target metric is described as imperfect, the estimate revisions suggest improving sentiment around the stock's fundamentals. The news is likely to be stock-specific rather than broadly market-moving.
Analysts' mean price target for Biodesix (BDSX) implies 104.3% upside, and the article notes broad agreement in raising earnings estimates. While the price-target metric is described as imperfect, the estimate revisions suggest improving sentiment around the stock's fundamentals. The news is likely to be stock-specific rather than broadly market-moving.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
